The introduction of new sedative agents as well as a desire for improved patient satisfaction, and greater efficiency has changed the practice of endoscopic sedation.
Dr Lawrence Cohen and colleagues designed a survey to provide national and regional data on endoscopic sedation, and practices in the US.
The team mailed a 22-item survey regarding current practices of endoscopy and sedation.
The surveys were sent to 5000 American College of Gastroenterology physician members nationwide.
|98% of procedures were performed with endoscopic sedation|
|American Journal of Gastroenterology|
The researchers reported that a total of 1353 questionnaires were returned.
Respondents performed an average of 12 esophagogastroduodenoscopies and 22 colonoscopies per week.
The team performed endoscopic procedures within a hospital setting more often than at an ambulatory center or private office.
More than 98% of esophagogastroduodenoscopies and colonoscopies were performed with endoscopic sedation.
The team noted that 74% of the respondents used a narcotic and benzodiazepine for sedation, while propofol was preferred by 26%.
Sedation practices varied considerably within different geographic regions of the United States.
Respondents routinely monitored vital signs and pulse oximetry.
The researchers observed that supplemental oxygen was administered to all patients during esophagogastroduodenoscopie by 73% of endoscopists.
Endoscopist satisfaction with sedation was greater among those using propofol than conventional sedation.
Dr Cohen's team concluded, “During the past 15 years, the volume of procedures performed by endoscopists in the United States has increased 2- to 4-fold.”“Propofol is currently being used for sedation in approximately 1 quarter of all endoscopies in the United States.”
“The findings from this survey may help in the formulation of updated policies, and practice guidelines pertaining to endoscopic sedation.”